Clinical trial
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm…
NCT00162903 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00162903 |
|---|---|
| Title | Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants |
| Official title | The Role of Nitric Oxide, Endothelin-1, and Inflammatory Mediators in the Patency of Ductus Arteriosus in Preterm Infants |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Patent Ductus Arteriosus |
| Enrollment | 80 |
| Start date | Jan 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Sep 13, 2005 |
| Last update posted | Nov 23, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: